A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells.

  1. J M Braughler,
  2. R L Chase,
  3. G L Neff,
  4. P A Yonkers,
  5. J S Day,
  6. E D Hall,
  7. V H Sethy and
  8. R A Lahti
  1. CNS Diseases Research Unit, Upjohn Company, Kalamazoo, Michigan.

    Abstract

    The compound U74006F (21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16 alpha-methyl- pregna-1,4,9(11)-triene-3,20-dione) is one of a novel series of 21-aminosteroids that are potent inhibitors of iron-dependent lipid peroxidation. Chronic (4-6 days) dosing of mice or rats with high doses of U74006F (30-200 mg/kg/day) has indicated that the compound is devoid of both glucocorticoid and mineralocorticoid activity. Although the compound is not a glucocorticoid antagonist, it markedly stimulated secretion of adrenocorticotropin by the murine pituitary tumor (AtT-20) cell. The enhanced secretion of adrenocorticotropin was not associated with an increased incorporation of [3H]thymidine or [14C]leucine into DNA or protein, respectively. Although not a glucocorticoid, U74006F also blocked the release of [14C]arachidonic acid from AtT-20 cells damaged by either Fe++ or the metabolic poison, iodoacetate. U74006F represents a novel class of antioxidant which displays cytoprotective activity and may uniquely affect cell growth or function in culture systems.

    « Previous | Next Article »Table of Contents

    This Article

    1. JPET February 1988 vol. 244 no. 2 423-427
    1. » Abstract
    2. Full Text (PDF)

    Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. December 2009, 331 (3)
    1. Current Issue
    1. Alert me to new issues of JPET